VIRGIN-VOYAGES
16.9.2019 22:34:07 CEST | Business Wire | Press release
Virgin Voyages, the new lifestyle brand that is shaking up the travel industry, has unveiled pieces from its stylish new uniform collection designed by maverick British fashion designer Gareth Pugh. The collection was showcased in a star-studded event during London Fashion Week last night.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190916005874/en/
The event at London's Royal Opera House featured a live surprise performance by Christina Aguilera. Christina Aguilera was dressed by Gareth Pugh in original designs featuring the capsule collection’s signature hues of red and black.
“People are at the heart of all of our Virgin companies and when our people feel their best, they help make guest experiences the best they can be,” said Sir Richard Branson, founder of the Virgin Group. “We want Virgin Voyages’ crew to be the happiest at sea and making sure that they feel comfortable, confident and stylish is a big part of that experience. Gareth Pugh and the Virgin Voyages’ team have worked hand-in-hand to bring to life what will soon be the most eye-catching uniforms on the high seas.”
A two-year project in the making, Pugh, widely considered the enfant terrible of the British fashion scene, joins Virgin Voyages’ Creative Collective-- an illustrious line up of designers, artists, and producers, including the likes of Tom Dixon, Roman and Williams and Mark Ronson, among others, who are collaborating with the company to transform how life at sea can look and feel.
The uniform collection pairs Pugh’s high-fashion modernist approach with Virgin Voyages’ design ethos of the Modern Romance of Sailing, which embodies a love of the sea and the glory and sophistication of the heyday of the ocean liner with a contemporary yacht-like style. The collection features a distinct combination of structure and fluidity and includes a wide range of looks from slick razor-sharp tailoring to relaxed pillow-case tunic shirts-- referencing the early days of British punk, and more.
“For this project, we were really allowed to push the boundaries, and to redefine the idea of what constitutes a uniform. We ultimately wanted to make everything about it modern, luxurious and desirable — to allow the entire crew to look and feel like a million dollars, in keeping with the rest of the experience,” said Pugh.
The collection allows for most crew to have a range of looks to choose from both day and night, and also breaks with cruise traditions by having no epaulettes stripes for officers, no ties and no waistcoats.
Putting a twist on the iconic red high-heel worn by Virgin Atlantic, many of Pugh’s designs will be paired with the Mulberry, red sneakers made by San Francisco-based PLAE. The gender neutral, PLAE sneakers are intended to playfully contrast Pugh’s designs for a cheeky yet elevated look true to the Virgin Voyages spirit. The Mulberry shoes were custom-designed for comfort and versatility- specifically to allow crew to be on their feet both day and night. Befitting of Virgin Voyages’ commitment to sustainability, PLAE’s shoes feature eco-friendly lining sourced from coffee grounds through sustainable technology and are manufactured in PLAE’s fair labor factory using water-based glue and renewable materials wherever possible.
The uniform collection reflects input from crew and Sir Richard Branson at each step of the design process. In anticipation of the company’s launch of its first ship, Scarlet Lady, next spring, Virgin Voyages partnered with sister-brands within the Virgin family in diverse roles around the globe to test the uniforms to ensure that the final designs would support a variety of job functions, climates and body types.
Future Sailors and First Mates are invited to check out Virgin Voyages by visiting www.virginvoyages.com .
ABOUT VIRGIN VOYAGES
Virgin Voyages is a global lifestyle brand committed to creating the world’s most irresistible holiday. With operations in the US, UK, and Europe, Virgin Voyages currently has four ships on order with master shipbuilder Fincantieri.
With its inaugural season scheduled for 2020, Virgin Voyages’ first ship Scarlet Lady was designed to reflect a yacht’s sleek luxury. Featuring spaces designed by some of the top names in contemporary design, Scarlet Lady will be Adult-by-Design, a sanctuary at sea for the 18+ traveler.
A dose of ‘Vitamin Sea’ will be naturally intertwined across the entire ship, with well-being activated through a mix of high-energy moments coupled with relaxation and rejuvenation. The Scarlet Lady will also feature alluring entertainment and 20+ world-class intimate eateries on board. Putting a twist on luxury, which the company refers to as Rebellious Luxe, Virgin Voyages will offer incredible value for its Sailors with all restaurants, group fitness classes, soft drinks, gratuities, WiFi and many more Virgin surprises included within the voyage fare.
Scarlet Lady will sail from Miami to the Caribbean in 2020, hosting more than 2,770 sailors and 1,150 amazing crew from around the world. Keep watch on virginvoyages.com for more updates.
Follow Virgin Voyages:
Instagram: @virginvoyages
Facebook: @virginvoyages
Twitter: @virginvoyages
LinkedIn: Virgin Voyages
YouTube: Virgin Voyages
ABOUT GARETH PUGH
Gareth Pugh is a British Fashion Designer and Creative Director.
His eponymous label has received global recognition for its approach to redefining modern luxury; described by Dazed & Confused as that which “shattered the monotony of an era of commercial fashion.”
Pugh made his London Fashion Week debut in 2005. He later won the ANDAM Fashion Award, presenting his first show in Paris in September 2008. He went on to present his first menswear collection in January 2009 and would remain on the Paris schedule for a further six years. In 2015, the designer celebrated the 10th anniversary of his label with a return to London Fashion Week. It proved a triumphant homecoming, with Vogue Runway describing his Spring/Summer 2016 show as “perhaps his best collection ever.”
Working alongside his partner and creative accomplice Carson McColl, Pugh has increasingly developed a distinct multi-disciplinary method. Widely recognised as a leading proponent of fashion film and new technology, over the past decade he has created some 20+ fashion films, most recently with the celebrated image-maker Nick Knight. He has also worked with some of the most popular artists of our time – including Beyoncé, Lady Gaga, Rihanna and Christina Aguilera — and collaborated with some of the world’s most important cultural institutions, designing shows for the Opéra Garnier in Paris and The Royal Opera House in London. Most recently he exhibited work at The Metropolitan Museum of Art as part of the Costume Institute’s 2019 Summer Exhibition.
In 2018 Pugh and McColl established HARD & SHINY, an independent creative studio specialising in fashion, film, stage design and experiential entertainment, with a roster of clients including Selfridges, MAC Cosmetics, Madison Square Garden and Sir Richard Branson’s Virgin Voyages.
Gareth Pugh is represented internationally by Raven PR and CXA New York.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190916005874/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
